Acute lymphoblastic leukemia (ALL) Treatment in Malaysia
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Acute Lymphoblastic Leukaemia (ALL)?
Acute Lymphoblastic Leukemia (ALL) is a malignancy involving the blood and bone marrow and is characterised by the abnormal growth of immature white blood cells (lymphoblasts). The incidence peaks in children, and adults may also be diagnosed with it.
What is the Importance of Timely Treatment?
- Improved Survival Rates: The sooner ALL is diagnosed and treatment begins, the stronger the possibility of remission and long-term survival.
- Prevention of Complications: It can result in serious complications, such as infection, bleeding, or disturbance in organ function. Prompt treatment thus reduces the chance of such life-threatening conditions, controls disease, and develops the immune response.
- Better Response to Treatment: The earlier the intervention for acute lymphoblastic leukaemia, the more probable it is for the patient to respond favourably to chemotherapy, stem cell transplantation, or other therapeutic regimes.
- Reduced risk of Relapse: Timely and aggressive treatment should ensure complete remission, reducing the chance of relapse. Earlier detection makes all of them easier to treat, with relapse prevention being critical for long-term outcomes.
- Quality of life: Due to early diagnosis and treatment, the patient is expected to suffer fewer side effects and enjoy an increased quality of life during and after treatment.
What are the Common Symptoms of Acute Lymphoblastic Leukemia (ALL)?
- Fatigue and Weakness
- Pale Skin
- Frequent Infections or Fever
- Easy Bruising or Bleeding
- Swollen Lymph Nodes
- Bone or Joint Pain
- Loss of Appetite or Unexplained Weight Loss
- Shortness of Breath or Dizziness
- Abdominal Pain or Fullness
Causes and Risk Factors of Acute Lymphoblastic Leukemia (ALL)
Causes
- Genetic Mutations
- Chromosomal Abnormalities
- Infections
- Immune System Disorders
- Exposure to Radiation or Chemicals
Risk Factors
- Age
- Family History
- Previous Cancer Treatment
- Environmental Exposures
- Genetic Syndromes
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Acute Lymphoblastic Leukemia (ALL) in Malaysia
Malaysia is oriented to evolve with advanced therapies and research programs in treating acute lymphoblastic leukaemia (ALL). Genomic studies using array-based comparative genomic hybridisation (array-CGH) helped detect copy number variations in Malaysian children suffering from ALL, thus opening doors to personalised medicine approaches. While CAR T-cell therapy is not yet widely available in Malaysia, various regional collaborations and clinical trials are examining the feasibility and accessibility of this therapeutic modality. Immunotherapeutic medications are also gaining traction in the clinical management of relapsed or refractory B-cell ALL. However, the availability of the drug in Malaysia may be limited.
Acute Lymphoblastic Leukemia (ALL) Prevention Tip:
- Radiation avoidance exposure: Minimise exposure from medical imaging radiation; high doses are associated with risk for ALL. They should be used to radiate only those individuals who are medically indicated.
- Protection from Harmful Chemicals: Long-term or repetitive exposure to chemicals such as benzene (mostly from industrial sources and some household products) and pesticides can be injurious and is related to leukemia.
- Healthy Lifestyle Choices: Healthy living practices such as maintaining a balanced diet, exercising, and avoiding tobacco smoking may still boost overall health and the immune system to prevent some cancers.
- Regular Medical Check-ups: Early detection matters. A regular check-up can identify unusual symptoms early, so if someone develops leukaemia, he or she will have a higher chance of successful treatment.
- Genetic Counselling: A genetic counsellor might inform people about future risks and early follow-ups to find loopholes, whereas such information is shared with people with existing leukaemia or heritable conditions such as Down syndrome.
Treatment options for Acute lymphoblastic leukemia (ALL)
The medical treatment for Acute Lymphoblastic Leukaemia (ALL) requires evaluating the patient's severity and medical condition. The following are the treatment options:
Chemotherapy : Chemotherapy for ALL always comes first: induction chemotherapy for remission, consolidation and maintenance chemotherapy to prevent relapse and maintain the remission.
Cost Start From USD 1500 - USD 3500Explore Options
Targeted Therapy : Tyrosine Kinase Inhibitors (TKIs), such as Imatinib, are used in Philadelphia chromosome-positive ALL, along with monoclonal antibodies, which target leukaemia cells and stimulate the immune response.
Cost Start From USD 2000 - USD 10000Explore Options
Stem Cell Transplantation : Allogeneic transplants from matched donors or autologous (using the patient's cells) are an option for high-risk or relapsed cases to restore normal blood cell production.
Cost Start From USD 20000 - USD 35000Explore Options
Immunotherapy : CAR-T cell therapy, a promising approach for patients with relapsed ALL, involves engineering the patient's T-cells to target and kill leukaemia cells. Immune checkpoint inhibitors are being explored to augment the immune response against leukaemia.
Cost Start From USD 15000 - USD 50000Explore Options
Radiation Therapy and Supportive Care: CNS-directed radiation is indicated for leukaemias that go into the brain, while supportive care measures such as blood transfusions and infection prevention can help ameliorate side effects and improve the patient's outcome during treatment.
CAR-T Cell Therapy : It emerges as a revolutionised therapy for patients with Acute Lymphoblastic Leukemia (ALL), particularly for patients with minimal responses to conventional treatment.
Cost Start From USD 75000 - USD 125000Explore Options
These are the standard diagnostic methods for diagnosing Acute Lymphoblastic Leukaemia (ALL):
Imaging Studies
- Chest X-rays or CT scans are utilised for the assessment of enlarged lymph nodes, spleen, liver, or other organ manifestations with potentially proven blood dissemination of leukaemia.
- Ultrasound: It evaluates organ enlargement, especially in the liver or spleen, which are commonly affected by leukaemia.
Blood Tests
- Complete Blood Count (CBC): CBC abnormalities can be seen in the levels of white blood cells, red blood cells, and platelets of a person with leukaemia. They manifest common signs of low blood counts, especially anaemia and thrombocytopenia.
- Peripheral Blood Smear: Under a microscope, a smear is made by spreading blood on a slide to check for immature white blood cells, known as blast cells, which are typical of ALL.
Bone Marrow Biopsy
- A core needle biopsy from the hip bone is taken to take a marrow sample for the presence of leukaemia cells. Blood cells are manufactured in the bone marrow, with leukemic cells displacing the healthy population and forming blood.
Lumbar Puncture (Cerebrospinal Fluid Analysis)
- Lumbar punctures (spinal taps) are done to see if leukaemia has spread into the central nervous system (CNS). During such an operation, a portion of cerebrospinal fluid (CSF) is extracted from the region surrounding the spinal cord and the brain to search for signs of leukaemia cells.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
- Rehabilitation: The purpose of physical therapy in the recovery process is to regain mobility and strength after chemotherapy or a stem cell transplant.
- Occupational Therapy: Occupational therapy assists patients in reclaiming familiar daily living skills such as dressing and cooking. It also gives skills in overcoming those cognitive challenges brought about by chemotherapy or radiation, thus improving mental function.
- Psychological Support: Patients suffering from stress in all treatments need emotional support, learning therapy, and support groups.
- Lifestyle Modification: Counselling from a dietitian will involve the creation of individualised meal plans to cope with symptoms such as loss of appetite, nausea, and other treatment effects.
- Pain Relief: Pain relief programs, such as medication, acupuncture, and massage therapy, are designed to ease the patient's discomfort after treatment.
Instantly Connect with our Specialists
Hospitals for Acute lymphoblastic leukemia (ALL) in Malaysia
ParkCity Medical Centre
Kuala Lumpur, Malaysia
In Kuala Lumpur, Malaysia, ParkCity Medical Centre is a 300-bed, cutting-edge, interdisciplinary private hospital that provides award-winning private healthcare in an environment of lush vegetation.
Bukit Tinggi Medical Centre
Kuala Lumpur, Malaysia
As a tertiary care hospital, Bukit Tinggi Medical Centre (BTMC) is committed to providing high-quality, reasonably priced healthcare.
With a focus on patient care and a team of committed medical professionals and personnel, we want to realize our ambition of becoming Klang's go-to healthcare provider. Orthopedics, neurosurgery, cardiac surgery, obstetrics and gynecology, pediatrics and rehabilitation, aesthetic surgery, and other specialties are all part of our multidisciplinary team approach. Additionally, BTMC has a Health Screening Center that provides a range of health packages to meet the requirements of diverse patient types.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Malaysia for Acute Lymphoblastic Leukemia Treatment?
- Advanced Oncology Centres: Malaysia boasts children’s hospitals with modern procedures for ACC.
- Expert Multidisciplinary Teams: Pediatric oncologists, surgeons, and radiologists cooperate to provide customised treatment.
- Minimally Invasive Surgery Options: Robotic and laparoscopic surgeries guarantee the fastest recovery with minimum scarring.
- Affordable World-Class Treatment: Medical care in Malaysia is high-standard yet more affordable than in other countries.
- Internationally accredited hospitals: JCI-accredited facilities treat cancer according to international protocols for safety and efficacy.
Frequently Asked Questions
Yes, relapse is likely, especially for high-risk cases. Management of relapse may include aggressive chemotherapy, stem cell transplant, or CAR-T cell therapy.
Cancer treatment can be accompanied by side effects, which could include fatigue alongside nausea due to the shedding of hair, further summing it all into the incidence of infections and, sometimes, anaemia. These could be followed by adverse consequences wherein development could have taken place before birth, for instance, those possible with children or perhaps concerns with fertility among adults.
Reputed hospitals have dedicated pediatric oncology units for treating children with ALL.
There are excellent transplant centres in Malaysia that offer matched and haploidentical transplants.
Depending on the staging and the protocol employed, it could take anywhere from a few months to a few years.
Yes, hospitals provide long-term post-treatment follow-ups for monitoring remission and relapse.
Stem cell transplants (autologous or allogeneic) are for high-risk or relapsed ALL patients. They restore healthy blood cells after the patient undergoes intensive therapy through chemotherapy or radiation.
Most cases are not hereditary; however, some genetic conditions, such as Down syndrome or Li-Fraumeni syndrome, may add to the likelihood of developing ALL. A family history of leukaemia may increase the risk in moderate amounts.
Yes, CAR-T cell therapy for either relapsed or refractory ALL is available in some specialised centres.
Malaysia has become well-known for second medical opinions: expert specialists, state-of-the-art diagnostic resources, and most of all, low cost. Efficient international patient services have very short waiting times. Medigence provides this service worldwide. To know more, visit our website.